ZIOPHARM Oncology Stock Price (NASDAQ:ZIOP)

Add to My Stocks
$5.88 $0.01 (0.17%) ZIOP stock closing price Mar 24, 2017 (Closing)
24 MAR 2017
amigobulls logo
ZIOP hand_up
ZIOP vs S&P 500
Closing Price: Mar 24, 2017
$5.88 ( 0.17%)
S&P 500
2344 ( -0.08%)
52 Week Price Range
1 Year Return: -18.02%
Q4 Growth*
Profitable ?
net image
2016 Q4 Net Loss
home image
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen

ZIOPHARM Oncology Snapshot Video

12 5 2

ZIOP Stock Details

Prev Close* : $5.87
Market Cap:
Day Low: $5.81
52 Week Low: $4.45
Open: $5.86
Volume: 778153
Day High: $6.04
52 Week High: $9.19

Latest Stock Market News

Latest Articles

ZIOPHARM Oncology News - From Partners

ZIOP Stockcharts

View ZIOP PE ratio, PS ratio stocks charts and compare with peers.
ZIOP Chart
Note: Compare ZIOPHARM Oncology stock price history with the index and industry peers.

ZIOPHARM Oncology Valuation

PS ratio (
price to sales ratio

ZIOPHARM Oncology Financial Ratios

Asset Turnover
Receivables Turnover

ZIOP Industry Peers

Company Price Change (%)
Co Lucid Pharma (CLCD)46.530 (0%)
Amarin (AMRN)3.190.05 (1.59%)
Nantkwest (NK)3.390.04 (1.17%)
Juno Therapeutics (JUNO)20.20.08 (0.39%)
Kite Pharma (KITE)76.842.34 (3.14%)
Incyte (INCY)139.640.67 (0.48%)
Celgene (CELG)123.380.16 (0.13%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Enzo Biochem (ENZ)8.430.52 (6.57%)
Peregrine Pharma (PPHM)0.7060.03 (4.44%)
Ophthotech (OPHT)3.530.15 (4.44%)
Kindred Biosciences (KIN)7.20.3 (4.35%)
Fortress Biotech (FBIO)3.60.14 (4.05%)
Immunomedics (IMMU)6.880.25 (3.77%)
Compugen (CGEN)4.350.15 (3.57%)
Top gainers from Medical-Biomed-Genetics industry
* As of Mar 25, 2017
CompanyPriceChange (%)
BioDelivery Sciences (BDSI)1.750.18 (9.35%)
Vital Therapies (VTL)3.850.15 (3.75%)
MannKind (MNKD)1.890.06 (3.08%)
PDL BioPharma (PDLI)1.980.05 (2.46%)
Sangamo BioSciences (SGMO)4.10.1 (2.38%)
Sorrento Therapeutics (SRNE)4.10.1 (2.38%)
Ultragenyx Pharma (RARE)70.321.67 (2.32%)
Top losers from Medical-Biomed-Genetics industry
* As of Mar 25, 2017

ZIOPHARM Oncology Inc. Stock News - Partner Headlines

ZIOPHARM Oncology Financial Statements

income statement20162015201420132012
Net Sales Or Revenues6.86M4.33M1.37M0.8M0.8M
Net Income-165.29M-120.08M-31.78M-57.1M-96.13M
Total Operating Expense172.16M124.42M44.86M58.51M102.96M
view ZIOPHARM Oncology Inc. income statement
balance sheet20162015201420132012
Total Assets106.34M153.72M45.23M71.75M83.4M
Total Liabilities183.64M66.35M11.39M22.37M34.95M
Shareholders Equity-77.29M87.37M33.84M49.38M48.44M
view ZIOPHARM Oncology Inc. balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities-20.91M44.43M1.64M-6.04M-0.93M
Net Cash From (Used By) Operating Activities-58.32M-0.01M-36.65M-59.5M-78.83M
Increase (Decrease) In Prop Plant And Equipment-0.55M-0.41M-0.19M-0.13M-1.55M
view ZIOPHARM Oncology Inc. cashflow statement

ZIOPHARM Oncology Stock Message Board

ZIOPHARM Oncology stock lost 0.17 %, and the last close price as of 24 Mar, 2017 is 5.88 for ZIOP stock. Looking at ZIOPHARM Oncology market capitalization, which currently stands at 777.05M, we can say that ZIOP stock is a Small cap stock. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing ZIOPHARM Oncology stock analysis.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that ZIOPHARM Oncology is worth a lot, it will most likely be reflected in an inflated ZIOPHARM Oncology stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 778153 shares were traded with a closing stock price of 5.88 as of 24 Mar, 2017, as can be seen from ZIOPHARM Oncology stock quote. One can view ZIOPHARM Oncology stock chart to follow the stock price trend. The board of directors decide what percentage of a company's earnings will be paid out as dividends. One can observe stock price trends and check for volatility by checking ZIOPHARM Oncology stock price history.